Published in Endocrinology on October 30, 2008
Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology (2009) 1.32
Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol (2009) 1.18
Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol (2012) 1.07
Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab (2009) 1.03
Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators. Int J Androl (2010) 1.02
Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats. Reproduction (2011) 0.96
Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin Reprod Med (2011) 0.96
Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol Reprod (2010) 0.95
Hypothalamic neuroendocrine functions in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture. PLoS One (2009) 0.91
Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep. Endocrinology (2013) 0.90
Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology (2010) 0.87
Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe. J Neuroendocrinol (2011) 0.83
Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion. BJOG (2010) 0.83
Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. Endocrinology (2012) 0.82
Exposure of female macaques to Western-style diet with or without chronic T in vivo alters secondary follicle function during encapsulated 3-dimensional culture. Endocrinology (2014) 0.82
Hyperinsulinaemic androgen excess in adolescent girls. Nat Rev Endocrinol (2014) 0.81
Developmental programming: Impact of prenatal testosterone treatment and postnatal obesity on ovarian follicular dynamics. J Dev Orig Health Dis (2012) 0.80
Developmental programming: postnatal estradiol amplifies ovarian follicular defects induced by fetal exposure to excess testosterone and dihydrotestosterone in sheep. Reprod Sci (2013) 0.80
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health. Mol Cell Endocrinol (2015) 0.78
Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models. Front Neuroendocrinol (2014) 0.78
Developmental programming: interaction between prenatal BPA exposure and postnatal adiposity on metabolic variables in female sheep. Am J Physiol Endocrinol Metab (2015) 0.77
Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions. Neuroendocrinology (2015) 0.77
Reproduction Symposium: developmental programming of reproductive and metabolic health. J Anim Sci (2014) 0.77
Developmental programming: postnatal estradiol modulation of prenatally organized reproductive neuroendocrine function in sheep. Reproduction (2016) 0.75
Prenatal testosterone exposure decreases colocalization of insulin receptors in kisspeptin/neurokinin B/dynorphin and agouti-related peptide neurons of the adult ewe. Eur J Neurosci (2016) 0.75
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Obesity. Lancet (2005) 17.67
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 12.27
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
Polycystic ovary syndrome. N Engl J Med (1995) 5.30
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
The epidemiology of obesity: the size of the problem. J Intern Med (2008) 3.62
Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science (1974) 3.20
Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics (2001) 3.17
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol (1986) 2.94
Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology (1974) 2.87
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 2.52
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab (2005) 2.50
Weight status in young girls and the onset of puberty. Pediatrics (2007) 2.49
Childhood obesity--the shape of things to come. N Engl J Med (2007) 2.09
The role of insulin receptor signaling in the brain. Trends Endocrinol Metab (2005) 2.01
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99
Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology (2008) 1.95
Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab (2000) 1.87
Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am (2003) 1.86
Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod (1998) 1.85
Obesity and androgens: facts and perspectives. Fertil Steril (2006) 1.78
Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) (2006) 1.76
The source of cerebral insulin. Eur J Pharmacol (2004) 1.73
Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ (2000) 1.65
Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord (2007) 1.61
Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int J Androl (2006) 1.57
Insulin and the blood-brain barrier. Curr Pharm Des (2003) 1.49
Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab (1998) 1.48
Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab (2002) 1.47
Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.44
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab (2006) 1.41
Radioimmunoassay for bovine and ovine luteinizing hormone. Endocrinology (1969) 1.40
Obesity and infertility. Curr Opin Endocrinol Diabetes Obes (2007) 1.37
Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab (1994) 1.35
Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab (2006) 1.30
Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female. Mol Cell Endocrinol (2006) 1.27
Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab (2005) 1.25
Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology (2005) 1.23
Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab (1998) 1.23
Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle. Rev Endocr Metab Disord (2007) 1.20
Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology (2003) 1.20
Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab (2000) 1.18
Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Obstet Gynecol Surv (2003) 1.12
Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep. Biol Reprod (2007) 1.11
Neuroendocrine basis of seasonal reproduction. Recent Prog Horm Res (1984) 1.08
Evidence for short or ultrashort loop negative feedback of gonadotropin-releasing hormone secretion. Neuroendocrinology (1995) 1.06
Cardiometabolic features of polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab (2008) 1.06
Early origins of polycystic ovary syndrome. Reprod Fertil Dev (2005) 1.05
Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome. J Clin Endocrinol Metab (2007) 0.98
Seasonal changes in gonadotropin-releasing hormone secretion in the ewe: alteration in response to the negative feedback action of estradiol. Biol Reprod (1993) 0.97
Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Update (2001) 0.95
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril (2008) 0.95
Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens) (2006) 0.95
Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct evidence for separate episodic and basal components of FSH secretion. Endocrinology (1997) 0.94
Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes (Lond) (2007) 0.94
Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function. Reprod Toxicol (2006) 0.92
Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids. J Clin Endocrinol Metab (2003) 0.91
Prenatal androgens time neuroendocrine sexual maturation. Endocrinology (1991) 0.90
Novel concepts about normal sexual differentiation of reproductive neuroendocrine function and the developmental origins of female reproductive dysfunction: the sheep model. Soc Reprod Fertil Suppl (2007) 0.89
Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril (2006) 0.86
Reproductive endocrinology and clinical aspects of obesity in women. Ann N Y Acad Sci (2008) 0.86
Effects of obesity on insulin sensitivity and responsiveness in sheep. Am J Physiol (1989) 0.85
Environment and origin of disease. Rev Endocr Metab Disord (2007) 0.83
Fat and growth during childhood. Science (1959) 0.82
Obesity and the reproductive axis. Ann Endocrinol (Paris) (2002) 0.80
Roles of the dominant follicle and the pattern of oestradiol in induction of preovulatory surges of LH and FSH in prepubertal heifers by pulsatile low doses of LH. J Reprod Fertil (1990) 0.80
Obesity in adolescent girls: is excess androgen the real bad actor? J Clin Endocrinol Metab (2006) 0.80
Insulin in the cerebrospinal fluid. Neurosci Biobehav Rev (1991) 0.79
Endocrine comparison of obese menstruating and amenorrheic women. J Clin Endocrinol Metab (1984) 0.78
Timing of puberty by photoperiod. Reprod Nutr Dev (1988) 0.78
Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients. Int J Fertil Womens Med (2008) 0.78
Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot. Int J Fertil Menopausal Stud (1993) 0.77
Cardiovascular risk in women with polycystic ovary syndrome. Minerva Endocrinol (2007) 0.77
The ovarian follicle and fertility. J Steroid Biochem Mol Biol (1991) 0.77
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect (2010) 5.19
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ Health (2014) 1.88
Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology (2003) 1.87
Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect (2014) 1.61
Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord (2007) 1.61
Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 1.61
Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep. Biol Reprod (2012) 1.51
Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab (2006) 1.51
Sensitivity and specificity of pulse detection using a new deconvolution method. Am J Physiol Endocrinol Metab (2009) 1.49
Bisphenol A and chronic disease risk factors in US children. Pediatrics (2013) 1.35
The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology (2009) 1.35
Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology (2005) 1.34
Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Cien Saude Colet (2012) 1.30
Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology (2006) 1.26
Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am J Physiol Endocrinol Metab (2005) 1.25
Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology (2007) 1.24
Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology (2005) 1.23
Regional uptake of meal fatty acids in humans. Am J Physiol Endocrinol Metab (2003) 1.23
Plasma free fatty acid storage in subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes (2008) 1.22
Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology (2003) 1.20
Meal fatty acid uptake in visceral fat in women. Diabetes (2007) 1.20
Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol (2009) 1.18
Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep. Biol Reprod (2002) 1.18
Hypertension caused by prenatal testosterone excess in female sheep. Am J Physiol Endocrinol Metab (2007) 1.15
Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol Reprod (2010) 1.15
Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ Health Perspect (2010) 1.13
Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology (2005) 1.13
Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes Res (2003) 1.12
Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One (2011) 1.12
Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol Reprod (2008) 1.10
Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod (2008) 1.09
Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil Steril (2002) 1.06
Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biol Reprod (2009) 1.04
Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biol Reprod (2007) 1.04
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril (2012) 1.04
Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One (2013) 1.03
Contributions of androgen and estrogen to fetal programming of ovarian dysfunction. Reprod Biol Endocrinol (2006) 1.01
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction (2009) 1.00
Polycystic ovary syndrome: an ancient disorder? Fertil Steril (2010) 0.99
Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev (2008) 0.99
Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study. J Clin Oncol (2009) 0.99
Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci (2010) 0.99
Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol (2007) 0.99
Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv (2008) 0.98
Programming of GnRH feedback controls timing puberty and adult reproductive activity. Mol Cell Endocrinol (2006) 0.98
Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. J Clin Endocrinol Metab (2006) 0.97
Prenatal testosterone excess reduces sperm count and motility. Endocrinology (2008) 0.97
Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) (2007) 0.97
Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. Am J Physiol Endocrinol Metab (2010) 0.96
Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol Reprod (2010) 0.95
Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause (2008) 0.95
Fetal programming: testosterone exposure of the female sheep during midgestation disrupts the dynamics of its adult gonadotropin secretion during the periovulatory period. Biol Reprod (2004) 0.95
Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep. J Physiol (2006) 0.95
Pluripotent stem cells derived from mouse and human white mature adipocytes. Stem Cells Transl Med (2014) 0.95
Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound. Fertil Steril (2006) 0.94
Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.93
Differential effects of prenatal testosterone timing and duration on phenotypic and behavioral masculinization and defeminization of female sheep. Biol Reprod (2008) 0.93
Prenatal exposure of the ovine fetus to androgens sexually differentiates the steroid feedback mechanisms that control gonadotropin releasing hormone secretion and disrupts ovarian cycles. Arch Sex Behav (2002) 0.93
Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus. Toxicol Appl Pharmacol (2010) 0.93
Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids (2013) 0.93
Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression. Endocrinology (2013) 0.92
Prenatal testosterone and dihydrotestosterone exposure disrupts ovine testicular development. Reproduction (2011) 0.92
Prepubertal administration of estradiol valerate disrupts cyclicity and leads to cystic ovarian morphology during adult life in the rat: role of sympathetic innervation. Endocrinology (2003) 0.91
Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol (2013) 0.91
Delivery type not associated with global methylation at birth. Clin Epigenetics (2012) 0.90
Insight into the neuroendocrine site and cellular mechanism by which cortisol suppresses pituitary responsiveness to gonadotropin-releasing hormone. Endocrinology (2007) 0.90
Prenatal testosterone treatment alters LH and testosterone responsiveness to GnRH agonist in male sheep. Biol Res (2008) 0.89
Developmental programming: gestational testosterone treatment alters fetal ovarian gene expression. Endocrinology (2011) 0.89
Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles. Fertil Steril (2012) 0.87
GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod (2004) 0.87
Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology (2010) 0.87
Expression of mRNA for galanin, galanin-like peptide and galanin receptors 1-3 in the ovine hypothalamus and pituitary gland: effects of age and gender. Reproduction (2008) 0.87
Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients. J Clin Endocrinol Metab (2004) 0.87
Long-term exposure of female sheep to physiologic concentrations of estradiol: effects on the onset and maintenance of reproductive function, pregnancy, and social development in female offspring. Biol Reprod (2006) 0.86
Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys. PLoS One (2012) 0.85
Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues. Endocrinology (2010) 0.84
Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic. Endocrinology (2002) 0.84
Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition. Fertil Steril (2007) 0.83
Environment and origin of disease. Rev Endocr Metab Disord (2007) 0.83
Developmental programming: postnatal steroids complete prenatal steroid actions to differentially organize the GnRH surge mechanism and reproductive behavior in female sheep. Endocrinology (2013) 0.83
Impact of gestational bisphenol A on oxidative stress and free fatty acids: Human association and interspecies animal testing studies. Endocrinology (2015) 0.82
Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. Endocrinology (2012) 0.82
Polycystic ovary syndrome--"A riddle wrapped in a mystery inside an enigma". J Clin Endocrinol Metab (2009) 0.82
Nonhuman primates contribute unique understanding to anovulatory infertility in women. ILAR J (2004) 0.81
Developmental programming: reproductive endocrinopathies in the adult female sheep after prenatal testosterone treatment are reflected in altered ontogeny of GnRH afferents. Endocrinology (2011) 0.81
Developmental programming: exogenous gonadotropin treatment rescues ovulatory function but does not completely normalize ovarian function in sheep treated prenatally with testosterone. Biol Reprod (2008) 0.81
In utero programming of sexually differentiated gonadotrophin releasing hormone (GnRH) secretion. Domest Anim Endocrinol (2002) 0.81
Diurnal changes in FSH-regulatory peptides and their relationship to gonadotrophins in pubertal girls. Hum Reprod (2004) 0.81
Participation of vasoactive intestinal polypeptide in ovarian steroids production during the rat estrous cycle and in the development of estradiol valerate-induced polycystic ovary. Reproduction (2007) 0.80